GREENWICH, CT, Nov. 30, 2015 /CNW/ - We are very pleased to announce that Jonathan Goldman, CEO of Aptuit, has accepted a nomination to join the Columbia University Healthcare Advisory Board. Jonathan will serve an initial three-year term on the board alongside other executives from leading pharmaceutical and healthcare principals, thought leaders and expert advisors.
(Logo: http://photos.prnewswire.com/prnh/20150709/234432LOGO )
Jonathan said that he was delighted to accept the nomination to join the board and that he views the appointment as a personal privilege, that he has the opportunity to give back to the school where he gained his MBA, and to help prepare the future leaders of our industry.
Matt Quam of Columbia Business School said of Jonathan, "We are delighted by your forthcoming involvement in this terrific program".
Columbia University Healthcare Advisory Board
The Advisory Board was established to support the Columbia Business School's Healthcare and Pharmaceutical Management Program's strategic planning and implementation processes.
The Program equips students to become well-rounded leaders prepared to handle the growing complexities of the healthcare sector. By attracting top-tier faculty, expanding its curriculum, developing a research platform and by strengthening ties with the healthcare network, the program can work toward its goal of transforming the healthcare industry on a global scale.
Members of the advisory board play a leading role in highlighting healthcare business-related education and programming at Columbia Business School and across the entire University, and are expected to provide insight - both individually and collectively - to the healthcare business network at large.
Aptuit LLC provides the most complete set of integrated early discovery to mid-Phase drug development services in the pharmaceutical industry including Drug Design & Discovery, API Development and Manufacture, Solid State Chemistry, CMC, Preclinical and IND enabling GLP/GMP programs. Fully integrated drug discovery & development services are available from a single site at the Aptuit Center for Drug Discovery & Development in Verona, Italy. The company maintains resources around the world, with facilities in the US, UK and Italy. Aptuit LLC is partnered with Welsh, Carson, Anderson & Stowe, one of the world's leading private equity investors.
For more information about Aptuit, visit http://www.aptuit.com or send an email to email@example.com
SOURCE Aptuit LLC